Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101556Source: DataRank Database

AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1 is a research paper published in Molecular Therapy — Methods & Clinical Development (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (15)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Shilpa Prabhakar ORCID,Alexandra L. Geffrey,Mohammed Mahamdeh ORCID,Tomeh Tomeh,Koen Breyne ORCID

Live enrichment

PubMed:40932991 OpenAlex:https://openalex.org/W4413163068

National Institutes of Health

Grant: K22 CA2802019-01

US Department of Defense

Grant: HT9425-24-1-0119

BridgeBio

Grant: HT9425-23-1-0338

NCI NIH HHS

Grant: K22 CA282019

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omtm.2025.101556

publisherhttps://doi.org/10.1016/j.omtm.2025.101556

publisherhttps://api.elsevier.com/content/article/PII:S2329050125001512?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050125001512?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40932991

Fields of Study

Tuberous Sclerosis Complex Research

Keywords

Tuberous sclerosisGenetic enhancementMedicineGeneBiologyPathologyGeneticsAAV9TSC1braingene replacementmicroglia activationmyelinationtuberous sclerosis complex